Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review

Similar documents
General Approach to Infectious Diseases

Appropriate antimicrobial therapy in HAP: What does this mean?

Int.J.Curr.Microbiol.App.Sci (2017) 6(3):

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

3/20/2011. Code 215 of Hammurabi: If a physician performed a major operation on

Le infezioni di cute e tessuti molli

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Intrinsic, implied and default resistance

Available online at ISSN No:

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Antimicrobial Prophylaxis in the Surgical Patient. M. J. Osgood

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Antibiotic Updates: Part II

Antimicrobial Pharmacodynamics

Antimicrobial Susceptibility Patterns

Aerobic bacterial infections in a burns unit of Sassoon General Hospital, Pune

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

During the second half of the 19th century many operations were developed after anesthesia

Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran

Acinetobacter species-associated infections and their antibiotic susceptibility profiles in Malaysia.

Necrotizing Soft Tissue Infections: Emerging Bacterial Resistance

Antimicrobial Resistance & Wound Infections. Li Yang Hsu 8 th April 2015

Source: Portland State University Population Research Center (

2017 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING TOTAL HIP AND KNEE ARTHROPLASTY

Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS

Copyright 2012 Diabetes In Control, Inc. For permission to reprint, please contact Heather Moran, Production Editor, at

Received: February 29, 2008 Revised: July 22, 2008 Accepted: August 4, 2008

Surveillance of Antimicrobial Resistance among Bacterial Pathogens Isolated from Hospitalized Patients at Chiang Mai University Hospital,

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Epidemiology and Microbiology of Surgical Wound Infections

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Sustaining an Antimicrobial Stewardship

Vibrio vulnificus. Vibrio vulnificus V. vulnificus. pectinata japonica)

Approach to pediatric Antibiotics

Intra-Abdominal Infections. Jessica Thompson, PharmD, BCPS (AQ-ID) Infectious Diseases Pharmacy Clinical Specialist Renown Health April 19, 2018

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh

Who should read this document? 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version? 3

Antimicrobial Cycling. Donald E Low University of Toronto

Antimicrobial susceptibility of clinical isolates from earthquake victims in Wenchuan

Central Nervous System Infections

These recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.

Nosocomial Infections: What Are the Unmet Needs

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi

Sepsis is the most common cause of death in

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Treatment of Surgical Site Infection Meeting Quality Statement 6. Prof Peter Wilson University College London Hospitals

Canadian Nosocomial Infection Surveillance Program 2018 SURVEILLANCE OF SURGICAL SITES INFECTIONS FOLLOWING HIP AND KNEE ARTHROPLASTY

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

ETX2514SUL (sulbactam/etx2514) for the treatment of Acinetobacter baumannii infections

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Surgical prophylaxis for Gram +ve & Gram ve infection

Pocket Guide to Diagnosis & Treatment of Vascular Graft Infections (VGI)

Surgical Site Infections (SSIs)

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Outline. Antimicrobial resistance. Antimicrobial resistance in gram negative bacilli. % susceptibility 7/11/2010

Microbiology of War Wounds AUBMC Experience

Management of Hospital-acquired Pneumonia

Treatment of septic peritonitis

Workplan on Antibiotic Usage Management

Tel: Fax:

Concise Antibiogram Toolkit Background

Multidrug-Resistant Acinetobacter

Other Beta - lactam Antibiotics

PHAMACOLOGY 2 nd EXAM QUESTIONS 2012/2013

DETERMINANTS OF TARGET NON- ATTAINMENT IN CRITICALLY ILL PATIENTS RECEIVING β-lactams

Rational use of antibiotics

Diabetic Foot Infection. Dr David Orr Consultant Microbiologist Lancashire Teaching Hospitals

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

Antimicrobial stewardship in managing septic patients

Original Articles. K A M S W Gunarathne 1, M Akbar 2, K Karunarathne 3, JRS de Silva 4. Sri Lanka Journal of Child Health, 2011; 40(4):

Multi-drug resistant Acinetobacter (MDRA) Surveillance and Control. Alison Holmes

Aerobic Bacterial Profile and Antimicrobial Susceptibility Pattern of Pus Isolates in a Tertiary Care Hospital in Hadoti Region

Clinical Characteristics, Antimicrobial Susceptibilities, andoutcomesofpatientswithchryseobacterium indologenes Bacteremia in an Intensive Care Unit

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

on February 12, 2018 by guest

Taiwan Crit. Care Med.2009;10: %

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Konsequenzen für Bevölkerung und Gesundheitssysteme. Stephan Harbarth Infection Control Program

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

Principles of Antimicrobial Therapy

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Scottish Medicines Consortium

Guidelines for the Initiation of Empirical Antibiotic therapy in Respiratory Disease (Adults)

Post-operative surgical wound infection

An Evidence Based Approach to Antibiotic Prophylaxis in Oral Surgery

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Scottish Medicines Consortium

Super Bugs and Wonder Drugs: Protecting the One While Respecting the Many

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Randomized Controlled Trial on Adjunctive Lavage for Severe Peritoneal Dialysis- Related Peritonitis

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

Initial Management of Infections in the Era of Enhanced Antimicrobial Resistance

Isolation, identification and antimicrobial susceptibility pattern of uropathogens isolated at a tertiary care centre

Witchcraft for Gram negatives

Empiric antimicrobial use in the treatment of dialysis related infections in RIPAS Hospital

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

Transcription:

University of Wollongong Research Online Faculty of Science, Medicine and Health - Papers Faculty of Science, Medicine and Health 2008 Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review Elias Lachanas University of Athens Periklis Tomos University of Athens Nicolaos Sfyras Ippokrateion Hospital Spiros Miyakis University of Athens, smiyakis@uow.edu.au Alkiviadis Kostakis University of Athens Publication Details Lachanas, E., Tomos, P., Sfyras, N., Miyakis, S. & Kostakis, A. (2008). Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. Surgical Infections, 9 (2), 201-204. Research Online is the open access institutional repository for the University of Wollongong. For further information contact the UOW Library: research-pubs@uow.edu.au

Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review Abstract Background: Mediastinitis resulting from surgical site infection may occur in 1% of patients undergoing median sternotomy. Methods: Case report and review of the pertinent English-language literature. Results: We report a case of mediastinitis caused by Acinetobacter baumannii, in a patient with multiple comorbidities who underwent cardiopulmonary bypass. Successful treatment consisted of surgical debridement, reconstruction, and ampicillin-sulbactam. Conclusions: Acinetobacter baumannii should be recognized as a potential causative agent of severe postoperative mediastinitis. Disciplines Medicine and Health Sciences Social and Behavioral Sciences Publication Details Lachanas, E., Tomos, P., Sfyras, N., Miyakis, S. & Kostakis, A. (2008). Acinetobacter baumannii mediastinitis after cardiopulmonary bypass: case report and literature review. Surgical Infections, 9 (2), 201-204. This journal article is available at Research Online: http://ro.uow.edu.au/smhpapers/222

SURGICAL INFECTIONS Volume 9, Number 2, 2008 Mary Ann Liebert, Inc. DOI: 10.1089/sur.2006.097 Acinetobacter baumannii Mediastinitis after Cardiopulmonary Bypass: Case Report and Literature Review ELIAS LACHANAS, 1 PERIKLIS TOMOS, 1 NICOLAOS SFYRAS, 2 SPIROS MIYAKIS, 3 and ALKIVIADIS KOSTAKIS 1 ABSTRACT Background: Mediastinitis resulting from surgical site infection may occur in 1% of patients undergoing median sternotomy. Methods: Case report and review of the pertinent English-language literature. Results: We report a case of mediastinitis caused by Acinetobacter baumannii, in a patient with multiple comorbidities who underwent cardiopulmonary bypass. Successful treatment consisted of surgical debridement, reconstruction, and ampicillin-sulbactam. Conclusions: Acinetobacter baumannii should be recognized as a potential causative agent of severe postoperative mediastinitis. ACINETOBACTER SPP. are recognized increasingly as pathogens causing nosocomial infections, associated with considerable morbidity [1,2]. We report a patient with multiple risk factors who developed sternal osteomyelitis caused by Acinetobacter baumannii after cardiac surgery. Successful treatment consisted of surgical debridement, followed by reconstruction using the pectoralis muscles as flaps, combined with administration of ampicillin-sulbactam. We discuss the limited number of cases of mediastinitis caused by Acinetobacter spp. reported in the English-language literature. To the best of our knowledge, this is the first report of A. baumannii mediastinitis complicating cardiopulmonary bypass, underlying the idea that this nosocomial organism should be considered in the differential diagnosis of pathogens causing severe postoperative infections. CASE REPORT A 60-year-old obese (body mass index 34.6), diabetic, hypertensive female smoker underwent complete myocardial revascularization using the left internal mammary artery via median sternotomy. An intra-aortic balloon pump (IABP) inserted via the left femoral artery-supported her low cardiac index for 24 h postoperatively. The postoperative course was complicated by lower-extremity compartment syndrome, resulting in common peroneal nerve injury despite fasciotomy. The patient was discharged on postoperative day 20, otherwise well. The patient was re-admitted two weeks postdischarge complaining of fever, sternal pain, and purulent discharge from the sternotomy scar. The admission temperature was 38.5 C, 1 2nd Propedeutic Department of Surgery, Athens University, Laikon Hospital, Athens, Greece. 2 Department of Cardiac Surgery, Ippokrateion Hospital, Athens, Greece. 3 3rd Department of Medicine, Athens University, Sotiria Hospital for Chest Diseases, Athens, Greece. 201

202 white blood cell count was 3,900/mm3 (89% neutrophils), C-reactive protein (CRP) concentration was 170 mg/l (normal 5 mg/l), and erythrocyte sedimentation rate (ESR) was 57 mm/h. The chest radiograph was normal. Computed tomography (CT) of the chest with three-dimensional reconstruction revealed extensive necrosis of the sternum (Fig. 1). There was no evidence of retrosternal space involvement. The patient was treated empirically with vancomycin for four days (until culture results were available) without improvement. Blood cultures were negative. Gram stain of pus from the sternal wound revealed non-motile gramnegative coccobacilli. The organisms were strictly aerobic, catalase-positive, and oxidasenegative. On culture (API 20NE system; BioMerieux API, Marcy l Etoile, France), the isolate was identified as Acinetobacter baumannii, following the simplified identification scheme proposed [3]. Susceptibility testing with a broth LACHANAS ET AL. microdilution method performed and interpreted according to standard guidelines [4] revealed the following minimum inhibitory concentrations (MICs) (mcg/ml): ampicillin 16; ampicillin-sulbactam 1; piperacillin 16; ticarcillin-clavulanic acid 8; cefuroxime 32; cefotaxime 8; ceftazidime 2; cefepime 1; imipenemcilastatin 0.5; gentamicin 1; amikacin 1; and ciprofloxacin 32. The diagnosis was postoperative infectious mediastinitis type IIIB [5] caused by Acinetobacter baumannii, and ampicillin-sulbactam (3 g every 6 h) was administered intravenously. The patient underwent pulmonary function tests and dobutamine stress echocardiography, which revealed small airways disease, no signs of myocardial ischemia, and a left ventricular ejection fraction of 60%. Therefore, surgical debridement and sternum reconstruction was undertaken. During the operation, wires and necrotic bone, cartilage, and soft tissue were removed, FIG. 1. Preoperative computed tomography scans of chest with three-dimensional reconstruction. (A) Thoracic cage. (B) Selected location in sternum, showing necrotic (dark) areas.

ACINETOBACTER BAUMANNII MEDIASTINITIS 203 and the sternal defect was reconstructed using pectoral muscles as flaps [6]. Recovery was uneventful, and the patient was discharged on oral ampicillin-sulbactam on the tenth postoperative day in excellent physical condition, with a normal hematologic profile and sternal stability. Acinetobacter baumannii grew from culture of the necrotic bone, with an identical susceptibility pattern. At follow-up three months later, the patient was free of symptoms, CRP and ESR were normal, and the surgical site was evaluated with a repeat three-dimensional CT scan and a threephase 99 technetium methylene-diphosphonate scintigram, revealing normal healing and osteoblastic activity, respectively. Antibiotic treatment was then discontinued. The patient remains well; she ceased smoking, and her diabetes control is optimal. DISCUSSION Postoperative mediastinitis (surgical site infection associated with sternal osteomyelitis, with [organ/space] or without [deep incisional] infection of the retrosternal space) occurs in approximately 1% of patients undergoing median sternotomy for cardiopulmonary bypass [5]. The mortality rate is high (14% 48%), and the cost of hospitalization is increased [7,8]. Diabetes mellitus, obesity, tobacco smoking, airways disease, the use of the left internal mammal artery as a graft for cardiopulmonary bypass, and the use of an IABP are among the risk factors for mediastinitis after sternotomy [9]; all these risk factors were present in our patient. Staphylococci (Staphylococcus aureus, S. epidermidis) are isolated in more than 70% of postoperative mediastinitis cases having an identifiable pathogen [10]. Mixed infections, including anaerobic species, may account for as many as 40% of cases [11]. The extent of the involvement of anaerobes in mediastinal infections still is debated; growth of these organisms in vitro is often laborious, whereas distinguishing anaerobes as true pathogens from commensal organisms is sometimes problematic [12]. Gram-negative organisms and fungi are infrequent isolates in mediastinal surgical site infections [10,11]. Acinetobacter baumannii is one of at least 21 Acinetobacter species. In clinical practice, genospecies 1 (A. calcoaceticus), 2 (A. baumannii), 3, and 13 are called Acinetobacter baumannii-calcoaceticus complex, representing approximately 80% of isolates from clinical infections [13]. In contrast with earlier beliefs (that A. baumannii opportunistically affected patients at high mortality risk), this organism is now an established pathogen of hospital infections, associated independently with a higher mortality rate [1,2]. Acinetobacter spp. most often cause ventilator-associated pneumonia, but may also cause blood stream infections, as well as other infections, such as intra-abdominal abscess, keratitis, and meningitis [1,14]. Acinetobacter mediastinitis is rare. A case of postoperative mediastinal infection caused by A. calcoaceticus has been reported in a patient with esophagotracheal fistula [15], and a case of A. baumannii (then termed A. anitratus) sternoclavicular septic arthritis has been associated with intravenous drug abuse [16]. To our knowledge, the case described here is the first reported in the English-language literature of mediastinal wound infection caused by A. baumannii after cardiopulmonary bypass. Interestingly, the first case of multi-drug-resistant A. baumannii mediastinitis after heart transplantation has been described recently [17], identifying this organism as an emerging pathogen for postoperative infections. Hospital-acquired infections caused by Acinetobacter spp. resistant to most broad-spectrum agents (with the usual exception of carbapenems and polymyxins) are encountered frequently worldwide [14], including our country [18]. The frequency of isolation and the susceptibility pattern of resistant isolates depends on local factors, such as infection control measures and local antibiotic use policies [14]. Antibiotic combinations have been given for multi-drug-resistant strains, with inconsistent outcomes [13]. The strain isolated from the present case was not multi-drug-resistant, and ampicillin-sulbactam was used. Sulbactam is active against Acinetobacter (i.e., in comparison with clavulanate and tazobactam), presumably because of the selective affinity to its penicillin binding proteins and more favorable pharmacokinetics [19]. Ampicillin-sulbactam in high

204 doses may be considered for the treatment of multi-drug-resistant strains if imipenem-cilastatin cannot be used or is contraindicated [13,19]. The optimal surgical treatment of mediastinal infections is debatable, and depends largely on the extent of tissue damage at the time of diagnosis [5,10]. When the diagnosis of sternal infection is delayed more than 20 days, optimal surgical treatment consists of prompt debridement followed by muscle flaps [10]; the latter procedure can be performed using the pectoralis muscles [5,6]. In addition to surgery, antibiotics should be administered; in cases with unidentified pathogens or in mixed infections, the drugs are directed against a broad spectrum of suspected pathogens, taking into account local patterns of resistance of the most common pathogens. ACKNOWLEDGMENT The authors thank Ms. Danielle Bowler for editing the manuscript. REFERENCES 1. Goh BK, Alkouder G, Lama TK, et al. Multi-drug-resistant Acinetobacter baumannii intra-abdominal abscess. Surg Infect 2005;6:345 347. 2. Robenshtok E, Paul M, Leibovici L, et al. The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: Risk factors and outcomes. J Hosp Infect 2006;64:282 287. 3. Bouvet PJ, Grimont PA. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987;138:569 578. 4. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Fourth edition. Approved Standard M7-A4. Wayne, PA. 1997. 5. El Oakley RM, Wright JE. Postoperative mediastinitis: Classification and management. Ann Thorac Surg 1996;61:1030 1036. 6. Tomos P, Lachanas E, Michail PO, et al. Alternative bi-pectoral muscle flaps for postoperative sternotomy mediastinitis. Ann Thorac Surg 2006;81:754 755. 7. Loop FD, Lytle BW, Cosgrove DM, et al. Sternal wound complications after isolated coronary artery LACHANAS ET AL. bypass grafting: Early and late mortality, morbidity and cost of care. Ann Surg 1990;49:179 187. 8. Nelson RM, Dries DJ. The economic implications of infection in cardiac surgery. Ann Thorac Surg 1986; 42:240 242. 9. Demmy TL, Park SB, Liebler GA, et al. Recent experience with major sternal wound complications. Ann Thorac Surg 1990;49:458 462. 10. Grossi EA, Culliford AT, Krieger KH, et al. A survey of 77 major infectious complications of median sternotomy: A review of 7,949 consecutive operative procedures. Ann Thorac Surg 1985;40:214 223. 11. Sarr MG, Gott VL, Townsend TR. Mediastinal infection after cardiac surgery. Ann Thorac Surg 1984;38: 415 426. 12. Citron DM. Specimen collection and transport, anaerobic culture techniques, and identification of anaerobes. Rev Infect Dis 1984;6 Suppl 1:S51 S58. 13. Murray CK, Hospenthal DR. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 2005;18: 502 506. 14. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9: 148 165. 15. Stoutenbeek CP, van Saene HK, Miranda DR, et al. Acinetobacter mediastinitis and pneumonia in a thorotrastoma patient: The oropharyngeal flora as source of infection. Intensive Care Med 1983;9:139 141. 16. Bayer AS, Chow AW, Louie JS, et al. Sternoarticualr pyoarthrosis due to gram-negative bacilli: Report of eight cases. Arch Intern Med 1977;137:1036 1040. 17. George RS, Birks EJ, Haj-Yahia S, et al. Acinetobacter mediastinitis in a heart transplant patient. Ann Thorac Surg 2006;82:715 716. 18. Maniatis AN, Pournaras S, Orkopoulou S, et al. Multiresistant Acinetobacter baumannii isolates in intensive care units in Greece. Clin Microbiol Infect 2003;9: 547 553. 19. Marques MB, Brookings ES, Moser SA, et al. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations. Antimicrob Agents Chemother 1997;41:881 885. Address reprint requests to: Dr. Spiros Miyakis 3rd Department of Medicine Athens University Sotiria Hospital for Chest Diseases Mesogeion 152 11527, Athens, Greece E-mail: miyakis@hotmail.com